Tech Center 1600 • Art Units: 1633 1699
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18382626 | CD47 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES | Non-Final OA | President and Fellows of Harvard College |
| 18658077 | METHODS OF TREATING MITOCHONDRIAL DISORDERS | Non-Final OA | The Regents of the University of California |
| 17440116 | AUGMENTATION OF T-CELL ACTIVATION BY OSCILLATORY FORCES AND ENGINEERED ANTIGEN-PRESENTING CELLS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17260222 | CHIMERIC ANTIGEN RECEPTOR T CELLS | Final Rejection | The Regents of the University of California |
| 17047975 | COMPOSITIONS AND METHODS FOR CYTOTOXIC CD4+ T CELLS | Non-Final OA | The Regents of the University of California |
| 18558811 | PHARMACEUTICAL COMPOSITION COMPRISING CHORION EXTRACT-DERIVED EXOSOMES AS ACTIVE INGREDIENT FOR PROMOTING OSTEOGENESIS | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18029750 | METHODS FOR IDENTIFYING MODULATORS OF NATURAL KILLER CELL INTERACTIONS | Final Rejection | The Johns Hopkins University |
| 18748469 | OSTEOGENIC COMPOSITIONS AND METHODS OF MAKING THE SAME | Non-Final OA | Alphatec Spine, Inc. |
| 17602277 | METHODS AND COMPOSITIONS FOR PROGRAMMING T CELL DIFFERENTIATION AND ENHANCING T CELL PROLIFERATION | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 17784935 | ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOF | Final Rejection | The General Hospital Corporation |
| 17760245 | CYTOTOXIC T CELLS DERIVED FROM HUMAN T CELL-DERIVED IPS CELLS | Non-Final OA | THE UNIVERSITY OF TOKYO |
| 17928674 | COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS USING CRISPR-BASED BASE EDITOR SYSTEMS | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 18660178 | METHODS FOR THE LONG-TERM EXPANSION OF GRANULOCYTE-MACROPHAGE PROGENITORS AND APPLICATIONS THEREOF | Non-Final OA | UNIVERSITY OF SOUTHERN CALIFORNIA |
| 18276416 | GENERATION OF INDUCED PLURIPOTENT STEM CELL LINES FROM HUMAN PATIENTS WITH MUTATIONS IN THE GLUCOKINASE GENE | Non-Final OA | Qatar Foundation for Education, Science and Community Development |
| 17782600 | ENHANCEMENT OF iPSC-DERIVED EFFECTOR IMMUNE CELL USING SMALL COMPOUNDS | Final Rejection | Fate Therapeutics, Inc. |
| 18116349 | METHOD FOR PRODUCING ASTROCYTE-LIKE CELLS | Final Rejection | KEIO UNIVERSITY |
| 18626460 | RECRUITMENT METHODS AND COMPOUNDS, COMPOSITIONS AND SYSTEMS FOR RECRUITMENT | Non-Final OA | Pairwise Plants Services, Inc. |
| 17759271 | BI-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING CD83 AND INTERLEUKIN 6 RECEPTOR | Final Rejection | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 18565425 | DUAL-LAYER CULTURE SUBSTRATE | Non-Final OA | WASEDA UNIVERSITY |
| 18517525 | SEPARATION DEVICE AND METHOD FOR SEPARATING TO-BE-SEPARATED MATERIAL USING SAME | Non-Final OA | NISSAN CHEMICAL CORPORATION |
| 17774088 | GENERATION OF CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FROM STEM CELLS AND THERAPEUTIC USES THEREOF | Final Rejection | City of Hope |
| 18517066 | METHOD FOR INDUCING AND DETECTING SOLUBLE LOX-1 (sLOX-1) IN CULTURED BLOOD CLOTS | Non-Final OA | GEORGE MASON UNIVERSITY |
| 17176422 | APPARATUS FOR SEPARATING THE CELLULAR AND LIQUID PORTIONS OF A WHOLE BLOOD SAMPLE | Final Rejection | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY |
| 18247651 | LONG-TERM AND FUNCTIONAL CULTURE OF HEPATIC ORGANOIDS (eHEPO) DERIVED FROM EPCAM+ ENDODERMAL PROGENITOR CELLS DIFFERENTIATED FROM INDUCED PLURIPOTENT STEM CELLS | Non-Final OA | KOC UNIVERSITESI |
| 17994883 | CHIMERIC ANTIGEN RECEPTORS (CARs), TARGETING HEMATOLOGIC MALIGNANCIES, COMPOSITIONS AND METHODS OF USE THEREOF | Final Rejection | iCell Gene Therapeutics Inc. |
| 18252627 | CULTURED ADIPOSE TISSUE | Non-Final OA | Trustees of Tufts College |
| 17912480 | ISCHEMIC HEART DISEASE ANIMAL MODEL USING 3-DIMENSIONAL BIOPRINTED OCCLUDE, AND MANUFACTURING METHOD THEREFOR | Final Rejection | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY |
| 17915802 | Cell | Non-Final OA | AUTOLUS LIMITED |
| 17915689 | METHOD FOR SELECTING CELLS EXPRESSING A NUCLEIC ACID OF INTEREST | Final Rejection | AUTOLUS LIMITED |
| 17436673 | COMPOSITIONS AND METHODS COMPRISING ENGINEERED CHIMERIC ANTIGEN RECEPTOR AND MODULATOR OF CAR | Non-Final OA | AUTOLUS LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy